4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-15-072515
Chief Executive Officer acquired 14,306 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Quart Barry D · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-09-29 | Exercise or conversion : show line 1 in the form | +14,306 | $7.20 | $103,003 | 70,055 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2015-09-29 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −14,306 | $7.20 | 2023-05-01 | 14,306 | 950,694 | D |
Loading xslF345X03/doc4.xml…